Sunday, November 4, 2012

Facebook; Level 3 Communications; StemCells; Stewart Enterprises

Facebook (FB) got a nice review from an analyst. "An equivalent valuation for Facebook is $135 billion or $54.47 per share. These numbers could even be conservative."

L-3 Communications (LLL) announced that its Security and Detection Systems division has been "awarded an indefinite-delivery/indefinite-quantity contract by the TSA to supply medium-speed explosives detection systems. This five-year acquisition program has a rev potential of $549.6 mln for L-3."

StemCells (STEM) announced it has partnered with R Biomedical to "develop and commercialize reagents for Human iPS Cell Research: The first product under the partnership, an 'ultra-primary' human fibroblast cell line from which researchers can generate iPS cell lines, was launched today under the SC Proven brand."

Stewart Enterprises (STEI) got a good review from Zachs Equity Research. "STEI is a good pick for investors seeking both growth and income, based on its solid third-quarter results, steady dividend yield and long-term earnings growth projection of 10.0%."

No comments:

Post a Comment